Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

一项II/III期随机对照试验研究方案：每周一次的紫杉醇纳米粒联合吉西他滨或卡铂对比吉西他滨/卡铂作为转移性三阴性乳腺癌患者一线治疗方案的比较（tnAcity研究）：